LUCARINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 4.490
EU - Europa 3.100
AS - Asia 1.984
SA - Sud America 213
AF - Africa 54
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.867
Nazione #
US - Stati Uniti d'America 4.439
RU - Federazione Russa 884
PL - Polonia 871
SG - Singapore 606
IT - Italia 533
CN - Cina 515
HK - Hong Kong 246
VN - Vietnam 229
IE - Irlanda 180
SE - Svezia 179
BR - Brasile 165
KR - Corea 139
DE - Germania 104
FR - Francia 77
FI - Finlandia 62
GB - Regno Unito 58
IN - India 56
UA - Ucraina 50
BD - Bangladesh 35
CA - Canada 35
CH - Svizzera 34
JO - Giordania 33
ID - Indonesia 29
AU - Australia 23
JP - Giappone 19
NL - Olanda 18
ES - Italia 16
IQ - Iraq 16
AR - Argentina 14
ZA - Sudafrica 14
MX - Messico 11
TR - Turchia 11
BE - Belgio 10
CI - Costa d'Avorio 9
PK - Pakistan 9
EC - Ecuador 7
CO - Colombia 6
MA - Marocco 6
NG - Nigeria 6
LV - Lettonia 5
MY - Malesia 5
VE - Venezuela 5
BJ - Benin 4
KG - Kirghizistan 4
LT - Lituania 4
PE - Perù 4
PY - Paraguay 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
IR - Iran 3
PT - Portogallo 3
AO - Angola 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
KE - Kenya 2
LB - Libano 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SC - Seychelles 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 9.867
Città #
Warsaw 866
Santa Clara 865
Ashburn 600
Singapore 423
Fairfield 380
Chandler 204
Hong Kong 198
Woodbridge 195
Dublin 178
San Jose 163
Houston 159
Seattle 141
Wilmington 140
Seoul 136
Cambridge 126
Beijing 125
Dallas 118
Florence 99
Milan 86
Hefei 82
Ann Arbor 79
Lawrence 62
Altamura 61
Jacksonville 59
Dong Ket 58
Los Angeles 55
Ho Chi Minh City 52
Rome 52
New York 51
Council Bluffs 49
Princeton 48
Buffalo 46
Lauterbourg 44
The Dalles 43
Boston 37
Hanoi 32
Boardman 31
Bern 30
Moscow 29
Munich 28
Helsinki 27
Kent 27
Jakarta 23
Melbourne 23
Mumbai 22
Medford 20
San Diego 20
Shanghai 19
Falls Church 17
Clifton 16
Paris 15
Tokyo 15
London 14
Montreal 14
Naples 14
Guangzhou 13
Orem 13
Frankfurt am Main 11
Norwalk 11
Turku 11
Phoenix 10
São Paulo 10
Tianjin 10
Abidjan 9
Baghdad 9
Chennai 9
Haiphong 9
Barcelona 8
Brussels 8
Chicago 8
Johannesburg 8
Redondo Beach 8
Toronto 8
West Jordan 8
Dearborn 7
Denver 7
San Francisco 7
Yubileyny 7
Barnet 6
Bologna 6
Brooklyn 6
Cape Town 6
Genoa 6
Abuja 5
Andover 5
Bengaluru 5
Guarulhos 5
Hillsboro 5
Manaus 5
Philadelphia 5
Ribeirão Preto 5
Riga 5
Rio de Janeiro 5
Sesto Fiorentino 5
Shenzhen 5
Turin 5
Verona 5
Amsterdam 4
Atlanta 4
Brasília 4
Totale 6.837
Nome #
Cyclooxygenase-2 and Inflammation Mediators Have a Crucial Role in Reflux-Related Esophageal Histological Changes and Barrett's Esophagus 359
CYTOKINE GENE EXPRESSION AND PRODUCTION BY HUMAN LPS-STIMULATED MONONUCLEAR CELLS ARE INHIBITED BY SULFATED HEPARIN-LIKE SEMI-SYNTHETIC DERIVATIVES. 344
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 340
PLASMATIC CARBONIC ANHYDRASE IX AS A DIAGNOSTIC MARKER FOR CLEAR CELL RENAL CELL CARCINOMA 323
A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy. 314
Different Antioxidant Efficacy of Two MnII-Containing Superoxide Anion Scavengers on Hypoxia/Reoxygenation-Exposed Cardiac Muscle Cells 295
2-Benzylpiperazine: a new scaffold for potent human Carbonic Anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. 277
A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia 271
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads 265
Role of histamine H3 receptor antagonists on intraocular pressure reduction in rabbit models of transient ocular hypertension and glaucoma 263
HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway 250
Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome 242
Effect of mediterranean diet enriched in high quality extra virgin olive oil on oxidative stress, inflammation and gut microbiota in obese and normal weight adult subjects 230
2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity 224
Protection from Cigarette Smoke-Induced Lung Dysfunction and Damage by H2 Relaxin (Serelaxin) 220
A new low molecular weight, Mn(II)-containing scavenger of superoxide anion protects cardiac muscle cells from hypoxia/reoxygenation injury. 214
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations. 213
Effects of new nsaid-cai hybrid compounds in inflammation and lung fibrosis 205
A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients 202
Histamine H4 receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress 196
Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis 192
Fibroblast autofluorescence in connective tissue disorders: a future tool for clinical and differential diagnosis? 192
Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodelling. 188
Histamine H4 receptor activation alleviates neuropathic pain through differential regulation of ERK, JNK and P38 MAPK phosphorylation 186
NCX 470 Exerts Retinal Cell Protection and Enhances Ophthalmic Artery Blood Flow After Ischemia/Reperfusion Injury of Optic Nerve Head and Retina 181
D-Tagatose Feeding Reduces the Risk of Sugar-Induced Exacerbation of Myocardial I/R Injury When Compared to Its Isomer Fructose 180
Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action 179
Is ectopia lentis in some cases a mild phenotypic expression of Marfan syndrome? Need for a long-term follow-up. 178
Discovery of Potent Dual-Tailed Benzenesulfonamide Inhibitors of Human Carbonic Anhydrases Implicated in Glaucoma and in Vivo Profiling of Their Intraocular Pressure-Lowering Action 176
Targeting the RNA-Binding Protein HuR Alleviates Neuroinflammation in Experimental Autoimmune Encephalomyelitis: Potential Therapy for Multiple Sclerosis 174
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. 173
Adenosine A3 Receptor (A3AR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice 170
Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy 169
Effects of a selective histamine H4r antagonist on inflammation in a model of carrageenan-induced pleurisy in the rat 167
Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy 165
Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment 164
Characterization of behavioral phenotypes in histamine H4-receptor knockout mice 162
NCX 470 Restores Ocular Hemodynamics and Retinal Cell Physiology After ET-1-Induced Ischemia/Reperfusion Injury of Optic Nerve and Retina in Rabbits 161
In vitro cell growth inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on human tumor cell lines with defective DNA damage response pathways 158
Repurposing Drug Metabolites into Dual β-Adrenergic Receptor-Carbonic Anhydrase Modulators as Potential Tools for Ocular Disorders 157
HISTAMINE H4 RECEPTOR ACTIVATION INDUCES ANTINOCICEPTION IN A NEUROPATHIC PAIN MODEL 153
COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy 150
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 150
One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes 150
The histamine h4 receptor participates in the anti-neuropathic effect of the adenosine a3 receptor agonist ib-meca: Role of cd4+ t cells 146
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit 138
Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy 137
Ullrich myopathy phenotype with secondary ColVI defect identified by confocal imaging and electron microscopy analysis. 113
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms 93
Thermosensitive chitosan-coated liposome-based gel for ocular delivery of cannabidiol: development, characterization, and in vivo evaluation 11
Totale 9.960
Categoria #
all - tutte 27.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.076


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022344 13 9 26 14 13 23 33 27 15 26 54 91
2022/2023937 84 203 47 71 62 136 108 59 101 8 19 39
2023/2024369 21 36 47 19 21 56 16 70 11 31 27 14
2024/20252.465 81 214 134 385 717 360 50 128 117 64 101 114
2025/20263.186 311 453 253 266 389 119 404 151 211 221 133 275
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 9.960